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Abstract
Mycobacterium tuberculosis (MTB), the agent of human tuberculosis remains a leading cause of
mortality globally. Its resurgence during the last two decades is a reflection of its opportunistic
relationship with HIV. The challenges associated with the disease are enormous and often debilitating.
The role of clinical and research laboratories is central and significant in this regard as prompt and
adequate diagnosis are key factors in the management and control of the disease.
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Résumé
Mycobactérie tuberculose, un agent de la tuberculose humaine est toujours une cause majeure des
morts dans le monde. Cette maladie qui est resurgie dans les deux derniers siècles, a un grand rapport
opportunistic avec le (HIV). La maladie est pleine de défis qui sont à la fois énorme et ennuyant. Dans
cet égard, les laboratoires et les hôpitaux jouent un rôle central et significatif, car les maîtres mots dans
le control et la maîtrise de cette maladie c’est le diagnostic suffisant et prompt.
Mots clés: Mycobactérie tuberculose, les défis, des enquêtes laboratoires, la résistance aux produits
pharmaceutiques
Introduction
The rising trend of (MTB) infection including cases of
multi drug resistant (MDR) strains reported in the
developing nations especially the Sub Saharan Africa






therapy short course) which advocates case
detection and treatment is central, in the global TB
control initiative while the diagnostic/research
laboratories provide useful information in; the
diagnosis of primary TB, treatment monitor, species
identification, drug susceptibility testing and strain
typing by DNA fingerprinting necessary for contact
tracing and epidemiological studies.
Routine identification of tubercle bacilli by
microscopic examination of clinical specimens
stained by Ziehl Neelsen’s method is recommended
as confirmatory for TB diagnosis.
4
This is quite useful
particularly for laboratories unable to perform
further diagnostic and identification procedures.
However, the present trend and pattern of MTB
infection which include its opportunistic and lethal
synergy with HIV, therapeutic complications due to
emergence of drug resistant MTB strains and
infection by non tuberculous mycobacteria species
(NTM species are inherently resistant to normal
doses of anti tuberculosis drugs)
5
necessitate the
scaling up of routine diagnostic procedures at least to
include culture, identification of causative
Mycobacterial species and drug susceptibility test.
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This article is an overview of laboratory diagnosis
of MTB infection and a call for nations in sub Saharan
Africa with high TB burden to scale up diagnostic
procedures beyond the routine Ziehl Neelsen’s
staining method. Nigeria for example has limited
laboratories proficient for standard
mycobacteriological examination.
Laboratory Identification Methods
Methods for the identification of MTB are
categorized as conventional (smear microscopy and




Smear microscopy for AFB is an important
preliminary step in the identification of MTB. It is
simple to perform, specific for acid fast bacilli and
serves as standard laboratory identification method
for detection of MTB in routine laboratories lacking
the facilities for Mycobacterial culture and further
identification procedures. The cheap and simple Ziehl
Neelsen’s staining for acid fast bacilli is widely used.
Other methods include; the Kinyoun’s acid fast
staining and Auramine Rhodamine fluorescene
staining. Their application may be as direct smear or
by concentration method.
6
The latter is a
centrifugation-sedimentation process after sputum
digestion. It is considered to yield higher positive
results than the direct sputum smear which involves
the direct use of clinical sample to prepare smear for
AFB staining. It has been estimated that about 50%-
80% of pulmonary tuberculosis will have positive
sputum smears.
4
The direct microscopy method is generally used in
routine clinical laboratories lacking the appropriate
biosafety facilities for protection and infection
containment.
The 5% sodium hypochlorite (bleach)
concentration method
6,7
has been recommended for
use in preference to the direct AFB method. Bleach
performs a dual function of sputum digestion and
mycobactericidal activity thus making the specimen
relatively safe to handle in the absence of a biosafety
cabinet.
Routine laboratories lacking the standard
biosafety facilities may need to comparatively review
the efficacy of the direct smear microscopy and the
bleach concentration methods with a view to
improve the detection of AFB in sputum.
The result of smear microscopy is vital for clinical
and epidemiological evaluation since it gives a
quantitative estimation of the number of bacilli being
excreted and thus an insight into the degree of
infectivity as well as the severity of the disease.
Grading of sputum samples by direct smear
microscopy:
1,6
1-9 AFB /100 oil immersion fields: Actual AFB
counts should be recorded (scanty)
10-99 AFB per oil immersion fields: +
1-10 AFB per field in at least 50 fields: ++
>10 per field in at least 20 fields: +++
The smear microscopic method is however
limited by; its inability to differentiate MTB from
NTM species, ability to detect only the actively





while paucy- bacillary cases often turn
out negative, ability to detect AFB of other microbial




Culture is considered a gold standard in clinical
bacteriology. It entails the cultivation of clinical
specimens on synthetic media for the purpose of
isolating the causative agent of a disease condition.
Mycobacterial culture is more sensitive than smear
microscopy as it is able to detect as few as 10 bacilli
per ml of digested concentrated clinical specimen.
4
Cultivation of MTB complex group (M. tuberculosis,
M. africanum, M. bovis, M. microti and M. canetti) is
difficult and time consuming, requiring 3 – 8 weeks
for primary isolation from clinical samples and 4–6
weeks for drug susceptibility tests.
6
Cultures of
mycobacterial species are however needful for
performance of biochemical identification tests, drug
susceptibility test and specific molecular methods
requiring the use of genomic DNA (eg, Restriction
fragment length polymorphism; RFLP).
Various mycobacteriological culture media are
available. These are categorised as; egg-potato-
based, egg-based (Lowenstein -Jensen’s) and agar
based (Middle Brook 7H-10, Middlebrook 7H-11 and
Dubois Oleic albumin) media.
Non conventional methods
Automated methods (radiometric and non
radiometric)
Automated methods are designed to yield results of
primary cultures and drug susceptibility tests within
the shortest possible period (4- 21 days). Their ability
to combine efficiency and reproducibility overcomes
most of the limitations of the conventional methods.
Automated machines are commercially available
from different manufacturers. These include;
The BACTEC 460 TB System (TB BACTEC), a





C-fatty acid substrate by
growing bacteria. The amount of
14
C02 released is
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expressed as growth index (GI) on a scale of 0 to 999.
In the presence of an antimicrobial agent, inhibition
of daily GI is considered as susceptibility of test
organism to the drug.
8,9
The handling and disposal of
radioactive medium in this technique is however
considered a disadvantage.
The mycobacteria growth indicator tube (MGIT)
960 (Becton Dickinson USA) uses a Middlebrook 7H9
broth in 7 ml plastic tube and a fluorescence
quenching-based oxygen sensor embedded at the
bottom of the tube. The procedure involves initial,
fluorescence quenching by presence of dissolved
oxygen in the broth. Subsequently, growing
mycobacterial cells in the inoculated tubes consume
the oxygen, producing fluorescence under 365nm UV
illumination. The system continuously monitors the
tubes to detect increase in fluorescence and
automatically determines and interprets results.
When used for drug susceptibility test, a set of drug
containing and drug free (growth control) media are
inoculated with the test strain. Comparison of
records in the test and control tubes are
automatically done and reported as susceptible or
resistant.
10,11
MB/BacT ALERT (BioMerieux, Durham) is a fully
automated and non radiometric system that utilizes a
bottle containing a colorimetric sensor embedded in
its bottom. Carbon dioxide produced by microbial
metabolism causes reduction in pH of medium and
changes the sensor color from dark green to yellow.
The color change is continuously monitored and
promptly reported by the instrument.
12,13
Reports of various studies have indicated the
efficiency of the different machines.
14-17
particularly
in the shorter turn out time (4-21 days) compared to
that of the conventional culture method (3- 8 weeks).
Their application may however be limited to research
and reference laboratories due to the high cost of
procuring the equipment and regular consumables.
Molecular methods
Molecular methods are genetic procedures that
make use of genetic materials (DNA or RNA) to detect
specific proteins or genes of the test organism using
specific probes or short stranded oligonucleotides
(primers) complementary to the test DNA strand.
The high degree of DNA polymorphism, repetitive
DNA sequences and presence of insertion sequences
(IS) characteristic of MTB strains have been used as




of specific regions in the MTB genome have been
done and cloned for use in detection identification
and typing from clinical samples and cultures.
22
Insertion sequence 6110 polymerase chain reaction
based diagnostic method
The IS6110 PCR technique is useful in the rapid
detection of MTB complex strains in clinical
specimens from naturally sterile anatomical sites
with minimal bacillary load, often undetectable by
the conventional methods. E.g. CSF, pleural effusion,
joint and marrow taps, gastric washings. The method
is cost-effective and simple to perform. It is specific,
sensitive, reproducible and able to generate results
within hours.
23,24
The target DNA is PCR amplified using IS6110
primers sequences. The amplified product is
electrophoresed using 2% agarose and observed by
UV illumination for DNA band of 123 base pair.
Molecular epidemiology/genotyping
Molecular epidemiology has been defined as the
integration of molecular techniques to track specific
strains of pathogen with conventional
epidemiological approaches to understanding the
distribution of disease in populations.
22
Molecular genotyping of MTB strains is useful in
outbreak investigations, comparison of isolates from
different laboratories and geographical regions and
contact tracing.
25,26
The short repetitive DNA
sequences and the insertion sequences characteristic
of MTB strains have been used as basis for designing
specific probes used in different techniques.
22
Studies
on the use of different methods such as the







interspersed repetitive units- Variable number of
tandem repeats) and other PCR based techniques
have been reported.
29
The goal, ultimately is to have a general
understanding of regional and global transmission of
MTB isolates and for strain tracking especially those
showing peculiar or unusual characteristics,
Drug susceptibility test (DST)
Performance of drug susceptibility test is useful for
the diagnosis of drug resistant and multi drug
resistant MTB isolates.
Drug resistant MTB: Resistance to one or more
than one of any anti tuberculosis drug
Multi drug resistance MTB (MDR): Resistance to
isoniazid and rifampicin with or without resistance to
other anti tuberculosis drugs.
Several techniques based on phenotypic and
genotypic principles have been developed for
determination of DST of MTB. Three (phenotypic)
methods are generally used in routine practice: The
absolute concentration method, resistance ratio
method and proportion method. The tests can be
performed by the direct inoculation of concentrated
specimen onto a set of drug containing media or
indirectly by using bacterial suspension of pure
cultures obtained from growth on synthetic media
(Lowenstein-Jensen, 7H10 or 7H11 agar).
The automated methods already described are
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comparatively more advantageous in producing
results within days to a few weeks.
Genotypic methods are useful in the
understanding of the molecular basis of drug








are used for rapid detection of
mutations associated with specific and multi drug
resistant tuberculosis.
Conclusion
The challenges associated with the present day
mycobacterial infection are issues of global concern.
The reliance on smear microscopy as the sole
laboratory diagnostic test common in low income
nations needs re-evaluation in the light of the rising
trend of tuberculosis associated with HIV/AIDS and
possible rise in prevalence of MDR MTB in a
community. Nationals that have high burdens of TB
and HIV infections (Notably, The Sub Saharan and
some Asian countries) should scale up laboratory
investigatory procedures to include the essentials
such as culture and drug susceptibility test.
There is need to differentiate MTB complex
strains (slow growers) from NTM (fast growers) to
enable prompt eradication of infecting strain from
the host.
The IS6110 diagnostic PCR for detection of MTB in
clinical specimens is cost-effective, easy to perform
and affordable for some routine laboratories in the
developing world.
Although the DNA fingerprinting methods are
research procedures, their importance and possible
application should be considered as epidemiological
records are vital for successful national infectious
disease prevention and control program.
Collaboration should be established between
laboratories with minimal facilities and the research
or reference laboratories to enable further
identification and typing of key isolates particularly
those that seem to defy antituberculosis
chemotherapy.
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